CY2026A - Use of 4H-1-benzopyran-4-one derivatives 4H-1-benzopyran-4-one derivatives and medicines containing same - Google Patents

Use of 4H-1-benzopyran-4-one derivatives 4H-1-benzopyran-4-one derivatives and medicines containing same

Info

Publication number
CY2026A
CY2026A CY202698A CY202698A CY2026A CY 2026 A CY2026 A CY 2026A CY 202698 A CY202698 A CY 202698A CY 202698 A CY202698 A CY 202698A CY 2026 A CY2026 A CY 2026A
Authority
CY
Cyprus
Prior art keywords
benzopyran
derivatives
containing same
medicines containing
compounds
Prior art date
Application number
CY202698A
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of CY2026A publication Critical patent/CY2026A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

Compounds of the formula I <IMAGE> in which the substituents R1-R5 and n and m have the said meanings, are suitable for controlling tumours. The present invention relates to the use of 4H-1-benzopyran-4-one derivatives, to 4H-1-benzopyran-4-one derivatives and to medicines containing same. Benzopyran derivatives have already been disclosed in European Patent No. 0137193 and German Offenlegungsschrift 36 12 337. In the latter, compounds of the formula a) are disclosed.
CY202698A 1988-10-28 1998-02-20 Use of 4H-1-benzopyran-4-one derivatives 4H-1-benzopyran-4-one derivatives and medicines containing same CY2026A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3836676A DE3836676A1 (en) 1988-10-28 1988-10-28 THE USE OF 4H-1-BENZOPYRAN-4-ON DERIVATIVES, NEW 4H-1-BENZOPYRAN-4-ON DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THEM

Publications (1)

Publication Number Publication Date
CY2026A true CY2026A (en) 1998-02-20

Family

ID=6366059

Family Applications (1)

Application Number Title Priority Date Filing Date
CY202698A CY2026A (en) 1988-10-28 1998-02-20 Use of 4H-1-benzopyran-4-one derivatives 4H-1-benzopyran-4-one derivatives and medicines containing same

Country Status (14)

Country Link
EP (1) EP0366061B1 (en)
JP (1) JP2879910B2 (en)
KR (1) KR100194505B1 (en)
AT (1) ATE133170T1 (en)
AU (1) AU628409B2 (en)
CA (1) CA1336715C (en)
CY (1) CY2026A (en)
DE (2) DE3836676A1 (en)
DK (1) DK175228B1 (en)
ES (1) ES2084593T3 (en)
GR (1) GR3018739T3 (en)
HK (1) HK1006167A1 (en)
IE (1) IE69982B1 (en)
PT (1) PT92145B (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284856A (en) * 1988-10-28 1994-02-08 Hoechst Aktiengesellschaft Oncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one derivatives
EP0508347A1 (en) * 1991-04-10 1992-10-14 Hoechst Aktiengesellschaft 5,7-Dihydroxy-2-methyl-8-[4-(3-hydroxy-1-(1-propyl)) piperidinyl]-4H-1-benzopyran-4-one, its preparation and its use
US5464871A (en) * 1993-05-12 1995-11-07 Octamer, Inc. Aromatic nitro and nitroso compounds and their metabolites useful as anti-viral and anti-tumor agents
US5733920A (en) * 1995-10-31 1998-03-31 Mitotix, Inc. Inhibitors of cyclin dependent kinases
ATE316799T1 (en) * 1996-03-12 2006-02-15 Sanofi Aventis Deutschland NOVEL PRODRUGS FOR THE THERAPY OF TUMORS AND INFLAMMATORY DISEASES
DE19802449A1 (en) * 1998-01-23 1999-07-29 Hoechst Marion Roussel De Gmbh Preparation of 3-hydroxy-1-methyl-4-phenyl-piperidine derivative isomer, for use as intermediate for antitumor agent flavopiridol
DE19959546A1 (en) * 1999-12-09 2001-06-21 Rhone Poulenc Rorer Gmbh Pharmaceutical preparation for the treatment of tumor diseases
US6821990B2 (en) 2000-01-18 2004-11-23 Aventis Pharma Deutschland Gmbh Ethanol solvate of (-)-cis-2-(2-chlorophenyl)-5, 7-dihydroxy-8 [4R-(3S-hydroxy-1-M ethyl) piperidinyl]-4H-1-benzopyran-4-one
US6576647B2 (en) 2000-01-18 2003-06-10 Aventis Pharmaceuticals Inc. Pseudopolymorph of (—)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8[4R-(3S-hydroxy -1-methyl)piperidinyl]-4H-1-benzopyran-4-one
DK1252155T3 (en) * 2000-01-18 2005-04-04 Aventis Pharma Inc Ethanol solvate of (-) - cis-2- (2-chlorophenyl) -5,7-dihydroxy-8- [4R- (3S-hydroxy-1-methyl) piperidinyl] -4H-1-benzopyran-4-one
FR2805538B1 (en) * 2000-02-29 2006-08-04 Hoechst Marion Roussel Inc NOVEL FLAVON DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF, THEIR USE AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND NOVEL USE
KR100392468B1 (en) * 2000-09-18 2003-07-22 주식회사 엘지생명과학 3-Hydroxychromene-4-on derivatives useful as cyclin dependendent kinase inhibitors
DE10113513A1 (en) * 2001-03-20 2002-10-02 Medinnova Ges Med Innovationen Drug combination of kinase inhibitor and neurotropic factor, useful for treating and/or preventing nerve and/or glial cell damage, e.g. associated with neurodegenerative diseases
US7547716B2 (en) 2001-06-08 2009-06-16 Institute Of Medicinal Molecular Design, Inc. Sulfonamide derivatives
PL211300B1 (en) 2002-04-17 2012-05-31 Cytokinetics Inc Compounds, compositions, and methods
TWI331034B (en) * 2002-07-08 2010-10-01 Piramal Life Sciences Ltd Inhibitors of cyclin-dependent kinases and their use
EP1539727B1 (en) 2002-07-17 2009-02-18 Cytokinetics, Inc. Compounds, compositions, and methods for treating cellular proliferative diseases
EP2429292B1 (en) * 2009-05-08 2019-04-03 Georgia State University Research Foundation Compounds and compositions comprising cdk inhibitors and their use in the treatment of cancer
EP4438734A2 (en) 2010-06-14 2024-10-02 The Scripps Research Institute Reprogramming of cells to a new fate
US20130225530A1 (en) 2010-07-12 2013-08-29 Dkfz Deutsches Krebsforschungszentrum Wogonin for the prevention and therapy of cardiac hypertrophy
WO2013113762A1 (en) 2012-01-31 2013-08-08 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and kits for predicting the risk of having a cutaneous melanoma in a subject
CN107995863A (en) 2015-04-20 2018-05-04 特雷罗药物股份有限公司 Response of the prediction to Avobenzene west ground is analyzed by mitochondria
AU2016264212B2 (en) 2015-05-18 2020-10-22 Sumitomo Pharma Oncology, Inc. Alvocidib prodrugs having increased bioavailability
WO2017024073A1 (en) 2015-08-03 2017-02-09 Tolero Pharmaceuticals, Inc. Combination therapies for treatment of cancer
WO2018094275A1 (en) 2016-11-18 2018-05-24 Tolero Pharmaceuticals, Inc. Alvocidib prodrugs and their use as protein kinase inhibitors
WO2019055579A1 (en) 2017-09-12 2019-03-21 Tolero Pharmaceuticals, Inc. Treatment regimen for cancers that are insensitive to bcl-2 inhibitors using the mcl-1 inhibitor alvocidib
EP3890749A4 (en) 2018-12-04 2022-08-03 Sumitomo Dainippon Pharma Oncology, Inc. Cdk9 inhibitors and polymorphs thereof for use as agents for treatment of cancer
WO2020191326A1 (en) 2019-03-20 2020-09-24 Sumitomo Dainippon Pharma Oncology, Inc. Treatment of acute myeloid leukemia (aml) with venetoclax failure
CN110028475B (en) * 2019-05-13 2022-07-01 中国药科大学 Novel CDK9 inhibitor based on benzopyran structure, preparation method and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3329186A1 (en) * 1983-08-12 1985-02-21 Hoechst Ag, 6230 Frankfurt CHROMONAL CALALIDE, METHOD FOR ITS INSULATION FROM DYSOXYLUM BINECTARIFERUM, AND ITS USE AS A MEDICINAL PRODUCT
IN164232B (en) * 1986-04-11 1989-02-04 Hoechst India

Also Published As

Publication number Publication date
KR100194505B1 (en) 1999-06-15
DK537289D0 (en) 1989-10-27
DE58909573D1 (en) 1996-02-29
IE893481L (en) 1990-04-28
CA1336715C (en) 1995-08-15
ES2084593T3 (en) 1996-05-16
AU628409B2 (en) 1992-09-17
DK537289A (en) 1990-04-29
DE3836676A1 (en) 1990-05-03
GR3018739T3 (en) 1996-04-30
JP2879910B2 (en) 1999-04-05
DK175228B1 (en) 2004-07-19
IE69982B1 (en) 1996-10-16
PT92145A (en) 1990-04-30
PT92145B (en) 1995-06-30
HK1006167A1 (en) 1999-02-12
JPH02178225A (en) 1990-07-11
ATE133170T1 (en) 1996-02-15
KR900006325A (en) 1990-05-07
EP0366061A1 (en) 1990-05-02
AU4384189A (en) 1990-05-03
EP0366061B1 (en) 1996-01-17

Similar Documents

Publication Publication Date Title
GR3018739T3 (en) Use of 4H-1-benzopyran-4-one derivatives, 4H-1-benzopyran-4-one derivatives and medicines containing same
IL101819A0 (en) Amidinophenylalanine derivatives,a process for the preparation thereof,use thereof and agents containing these as anticoagulants
IL86456A0 (en) Tetrazole derivatives useful as intermediates for preparing antihypertensive compounds
ZA925128B (en) Pyrrolidine derivatives,their preparation and medicaments containing them
AU4419193A (en) Synthesis of 1,4,7-triazacyclononane derivatives
IL89691A0 (en) Pharmaceutical compositions containing bis(3,4-dihydro-2h-1-benzopyran)derivatives for lowering blood pressure,certain such novel compounds and their preparation
ES2010114A6 (en) 7-(1-Azetidinyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic-acid derivatives, their preparation and their use as medicaments.
DK0553890T3 (en) Diphenylheteroalkyl derivatives, their manufacture and pharmaceuticals and cosmetically prepared therefrom
EP0530505A3 (en) Hydantoin derivatives
HU9201288D0 (en) Kinoxalyne derivatives, process for their production and medical preparations containing them
IL98262A0 (en) Chromone derivatives and pharmaceutical compositions containing them
ES2086065T3 (en) PREPARATION OF SUBSTITUTED TETRAHIDROPIRIDINAS.
ZA932359B (en) 3-Aminochroman spiro compounds processes for preparing them and pharmaceutical compositions containing them
NO903291D0 (en) PURINE-INHIBITING AMINOOLIGO HYDROXY DERIVATIVES.
GR3025290T3 (en) Novel 2h-benzo b)pyrane derivatives substituted in the 4 position by aryl or n-heteroaryl, process for producing them and preparations containing the compounds
HUT54682A (en) Process for producing 13-bromine- and 13,14-dibromine-ergoline derivatives and pharmaceutical preparatives containing these compounds
ZA924888B (en) Process for the synthesis of enantiomers of 3-aminochroman compounds
ATE119394T1 (en) USE OF MYRICETIN-3-0-BETA-D-GLUCURONIDE AS A MEDICINAL PRODUCT.
ZA917001B (en) Medicaments containing substituted 2-cyclohexene derivates and their use for the control of diseases
ZA874878B (en) Pyran derivatives